Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
Helen Tager-Flusberg
Boston University
From this contributor
Why no one needs a diagnosis of ‘social communication disorder’
A diagnosis of social communication disorder only keeps people from a community and resources they desperately want and need.
Why no one needs a diagnosis of ‘social communication disorder’
By
Helen Tager-Flusberg
17 April 2018 | 1 min read
Should scientists study mothers of children with autism?
Studying parents of children with autism has long been controversial, but that doesn’t mean scientists should avoid it.
Should scientists study mothers of children with autism?
By
Helen Tager-Flusberg
12 April 2016 | 1 min read
‘Frozen’ offers glimpse of autism in girls
Elsa, the star of the movie “Frozen,” is the poster child for girls with autism.
‘Frozen’ offers glimpse of autism in girls
By
Helen Tager-Flusberg
15 September 2015 | 4 min read
Time for some soul-searching in science
Scientists should slow down and return to the basic tenets of research to regain the public’s trust.
Time for some soul-searching in science
By
Helen Tager-Flusberg
1 September 2015 | 1 min read
Better behavioral tests may save trials of autism treatments
Trials to test drugs for autism suffer from subjective measurements and placebo effects. Helen Tager-Flusberg outlines how to ferret out the true effects of potential autism therapies.
Better behavioral tests may save trials of autism treatments
By
Helen Tager-Flusberg
21 April 2015 | 1 min read
Explore more from The Transmitter
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
By
Katie Moisse
15 December 2025 | 7 min read
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
By
Alex Kwan
15 December 2025 | 6 min read
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
By
Claudia López Lloreda
12 December 2025 | 5 min read